AICDA and myeloid sarcoma: In both analyses, age was a significant predictor (MS + AID vs. MS without AID: p < 0.001; HR: 0.955, 95% CI 0.930–0.980; MS + ABF vs. MS without AID and without ABF: p = 0.006; HR: 0.956, 95% CI 0.926–0.987).